Basilea Pharmaceutica Ltd. Logo

Dr. Marc Engelhardt, Chief Medical Officer

Dr. Marc Engelhardt  
Dr. Marc Engelhardt, German citizen, serves as Chief Medical Officer since January 2018. He succeeds Prof. Achim Kaufhold who retired as of December 31, 2017. Dr. Engelhardt joined Basilea in 2010 as Head of Clinical Research. In 2012, he was promoted to Head of Development. In this role Dr. Engelhardt led Basilea’s clinical research and development group, and acted as Prof. Kaufhold's deputy. Prior to joining Basilea, Dr. Engelhardt served as Global Program Medical Director at Novartis Pharma AG in Basel, before which he held various positions with increasing responsibility at Bracco-Altana, Konstanz, Germany and Bracco Diagnostics in Princeton, NJ, USA. Dr. Engelhardt holds a medical degree and a PhD from the University Frankfurt/Main, Germany and is board certified in internal medicine.